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Available online 10 February 2017VitaminD plays a critical role in skeletal homeostasis. VitaminD supplementation is usedworldwide tomaintain
optimal bone health, but themost appropriate level of supplementation remains controversial. This study aimed
to determine the effects of varying doses of dietary vitamin D3 on the mechanical properties and morphology of
growing bone.
Eight-week-old female mice were supplied with one of 3 diets, each containing a different dose of vitamin D3:
1000 IU/kg (control), 8000 IU/kg or 20,000 IU/kg. Mice had ad libitum access to the specialty diet for 4 weeks be-
fore they were culled and their tibiae collected for further analysis. The collected tibia underwent three-point
bending and reference-point indentation fromwhich their mechanical properties were determined, and cortical
and trabecular morphology determined by micro computed tomography.
Dietary supplementation with 20,000 IU/kg vitamin D3 resulted in greater ductility (~200%) and toughness
(~150%) compared to the 1000 IU/kg control. The 20,000 IU/kg dietwas also associatedwith signiﬁcantly greater
trabecular bone volume fraction and trabecular number. The 8000 IU/kg diet had no signiﬁcant effect on trabec-
ular bone mass.
We conclude that vitamin D3 supplementation of 20,000 IU/kg during early adulthood leads to tougher bone that
ismore ductile and less brittle than that of mice suppliedwith standard levels of dietary vitamin D3 (1000 IU/kg)
or 8000 IU/kg. This suggests that dietary vitamin D3 supplementation may increase bone health by improving
bone material strength and supports the use of vitamin D3 supplementation, during adolescence, for achieving
a higher peak bone mass in adulthood and thereby preventing osteoporosis.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Bone strength1. Introduction
It is generally established that vitamin D3 is crucial for bone health
through its actions as a regulator of minerals, and in turn, skeletal ho-
meostasis in vertebrates (Anderson et al., 2011). Deﬁciencies in vitamin
D3 during childhood can have signiﬁcant health consequences such as
growth retardation (Rajakumar, 2003) and detrimental effects on
bonemineral acquisition (Lehtonen-Veromaa et al., 2002) and bone re-
modelling (Outila et al., 2001; Cheng et al., 2003; Fares et al., 2003) lead-
ing to rickets (O'Riordan and Bijvoet, 2014). These consequences in
adolescence are also a signiﬁcant risk factor for the development of
osteoporosis later in life (Dawson-Hughes et al., 1991; Lips, 2001).
The effects of vitamin D3 as a treatment for osteoporosis in adult-
hood are controversial. Conﬂicting reports suggests vitamin D3The University of Melbourne, 28
. This is an open access article undersupplementation in adulthood reduces (Bischoff-Ferrari et al., 2005;
Tang et al., 2007), has no effect (Michaëlsson et al., 2003), or increases
the incidence of osteoporotic fractures (Smith et al., 2007; Sanders et
al., 2010). By comparing and normalising 23 separate studies, Reid et
al. (2013) found that vitaminD supplementationwas not effective in re-
ducing fracture risk in those not experiencing vitamin D deﬁciency.
An alternative strategy for preventing osteoporosis is to optimise
peak bone mass during growth via vitamin D3 supplementation during
adolescence. A number of intervention studies examining the effect of
vitaminD3 supplementation in adolescents have reported signiﬁcant in-
creases in bone mineral content (BMC) (El-Hajj Fuleihan et al., 2006;
Viljakainen et al., 2006) and bone mineral density (BMD) (Du et al.,
2004), while other studies have reported no beneﬁcial effects
(Andersen et al., 2008). Recent systematic reviews and meta-analysis
(Winzenberg et al., 2010; Winzenberg et al., 2011) have concluded
that vitamin D3 supplementation during adolescence had no signiﬁcant
effect on BMC and BMD, however there has been no randomised con-
trolled trial to assess the effect of vitamin D3 supplementation on bonethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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children and adolescents is 400 IU (Wagner and Greer, 2008). This dos-
age is based on clinical trials measuring biomarkers of vitamin D3 status
and the indirect observations that 400 IU of vitamin D3 prevents and
treats rickets (Wagner et al., 2006; Rajakumar and Thomas, 2005).
It is clear that there is a need for further investigation into the effect
of vitamin D3 dietary supplementation on bone mass in a model of
growing bone where subjects are vitamin D3 replete. Therefore, our ob-
jective was to determine whether increasing dietary vitamin D3 levels
(8000 and 20,000 IU/kg) above the standard levels (1000 IU/kg) signif-
icantly alters bone mass and strength in growing mice.
2. Methods and animals
2.1. Animals
7 week old female C57Bl/6 J mice were obtained from Monash Ani-
mal Services, Victoria and housed in a temperature and humidity con-
trolled environment on a 12 h light/dark cycle. All animal work was
approved by Victoria University Animal Ethics Committee. All animals
were fed on standard growth diet (AIN-93G, containing 0.47% calcium
(Ca), 0.35% phosphate (PO4), vitamin D3 1000 IU/kg) from weaning
until 8 weeks of age, at which point the animals were randomly allocat-
ed to one of three diets for a period of 4 weeks. These diets were mod-
iﬁed AIN-93G diets supplemented with set concentrations of
cholecalciferol (vitamin D3) as follows: control (1000 IU/kg, n = 10),
8000 IU/kg (n = 10) or 20,000 IU/kg (n = 7). The animals had ad
libitum access to both food & water. All animals consumed the same
amount of food (average of 2.5 g per day, no signiﬁcant difference be-
tween groups). At 12weeks of age, themicewere deeply anaesthetized
with pentobarbital sodium (60 mg/kg injection i.p.), killed by cervical
dislocation, and their tibiae harvested. Tibiae were carefully dissected
free from soft tissues; lengths measured with a digital caliper, and
stored at−80 °C prior to mechanical testing and further analysis.
2.2. Micro computed tomography (μCT)
Tibiae were analyzed by micro-computed tomography as described
previously (Johnson et al., 2014) using the SkyScan 1076 System
(Bruker-microCT, Kontich, Belgium). Images were acquired using the
following settings: 9 μm voxel resolution, 0.5 mm aluminium ﬁlter,
44 kV voltage, and 220 μA current, 2300 ms exposure time, rotation
0.5°, frame averaging=1. The imageswere reconstructed and analyzed
using SkyScan Software programsNRecon (version 1.6.3.3), DataViewer
(version 1.4.4), and CT Analyser (version 1.12.0.0) as previously de-
scribed (Johnson et al., 2014).
CTAn software was then used to select the regions of interest for
both the cortical (CTAn version 1.15.4.0) and trabecular (CTAn version
1.11.8.0) bone of each scan. Trabecular region of interest (ROI) was se-
lected as a 2 mm region starting 0.5 mm below the proximal growth
plate. Cortical ROI was selected as a 1 mm region starting 7 mm below
the growth plate. The cortical ROI was chosen such that the middle of
the ROI corresponded with the point at which load was applied to the
bones in the three-point bending experiments.
The analysis of bone structure was completed using adaptive
thresholding (mean of min andmax values) in CT Analyser. The thresh-
olds for analysis were determined based on multilevel Otsu
thresholding of the entire data set, andwere set at 45–255 for trabecular
bone and 71–255 for cortical bone.
2.3. Three point bending
Each tibia was rehydrated overnight in phosphate buffered saline
(PBS) at room temperature prior to testing. To determine the mechan-
ical properties of cortical bone each tibia was loaded to failure at
0.5 mm/s using a Bose Biodynamic 5500 Test Instrument (Bose, DE,USA). The span between the lower supports was 10 mm. Prior to test-
ing, the tibiae were kept moist in gauze swabs soaked in PBS. Bones
were positioned such that the load was applied 8.75 mm from the top
of distal condyle in the anterior-posterior (AP) direction with distal
condyle facing downwards (Supplementary Fig. 1). Wintest software
(WinTest 7) was used to collect the load-displacement data across
10 s with a sampling rate of 250 Hz. Structural properties including Ul-
timate force (FU; N), yield force (FY; N), stiffness (S; N/mm), and energy
(work) to failure (U; mJ) (Johnson et al., 2014) endured by the tibia
were calculated from the load and displacement data as outlined in
Jepsen et al. (2015). The yield point was determined from the load dis-
placement curve at the point at which the curve deviated from linear.
Widths of the cortical mid-shaft in the medio-lateral (ML) and antero-
posterior (AP) directions, moment of inertia (Imin), and the average cor-
tical thickness were determined by μCT in the cortical region described
above. Tibialmaterial properties, i.e., stress–strain curveswere calculat-
ed from the structural properties (i.e., load-displacement curve) in
combination with morphological data from μCT as outlined in Turner
and Burr (1993). The obtained stress–strain curves reﬂect the stiffness,
strength and failure properties of the bone material itself without the
inﬂuence of geometry.
2.4. Reference-point indentation
Local bonematerial properties at the tibialmid-shaftwere examined
by reference point indentation (RPI) as previously described (Tang et al.,
2007) using a BP2 probe assembly apparatus (Biodent Hfc, Active Life
Scientiﬁc Inc., Santa Barbara, CA, USA). The BP2 assembly includes a
90-degree cono-spherical test probe with a ≤5 μm radius point and a
ﬂat bevel reference probe with ~5 mm cannula length and friction
b0.1 N. Each sample was indented 5 times with the initial indentation
occurring on the anterior surface of the bone, 6mm from the tibia-ﬁbula
joint along themidline of the bone. Subsequent indentationswere taken
by moving the sample left, right, forwards or backwards approximately
1 mm in each direction from the initial indentation. The machine was
used with the following settings; indentation force 2 N, 2 indentations
per sec (Hz), 10 indentation cycles per measurement and touchdown
force of 0.1 N. The distance the probe travels into the bone (total inden-
tation distance [TDI]) is a measure of the bone's resistance to fracture;
indentation distance increase (IDI) is the indentation distance in the
last cycle relative to theﬁrst cycle and is correlated to bone tissue rough-
ness; average unloading slope indicates the compressibility of the bone
and can be used as a measure of stiffness (Johnson et al., 2014).
2.5. Statistics
All graphs are represented as the mean of all biological replicates.
The number of animals (n) is reported on the graph or in the ﬁgure leg-
ends. All error bars are standard error of the mean. Signiﬁcant differ-
ences were identiﬁed by one-way ANOVA with Tukey's post-hoc test
(GraphPad Prism 6.0 software). Statistical signiﬁcance was considered
p b 0.05.
3. Results
3.1. Effects of vitamin D3 dietary intervention on tibial structural properties
The highest level of dietary vitamin D3 (20,000 IU/kg), but not the
8000 IU/kg dose was associated with a signiﬁcantly greater (116%)
failure displacement when compared to the control group (Fig. 1A).
The 20,000 IU/kg diet was also associated with signiﬁcantly greater
post-yield displacement compared to the control (206%), and the
8000 IU/kg (154%) group (Fig. 1B). Tibiae from mice supplied with
20,000 IU/kg dietary vitamin D3 also showed a signiﬁcantly greater
work-to-failure compared control tibiae (153%) (Fig. 1C). Varying die-
tary vitaminD3 levels had no signiﬁcant effect on ultimate load, ultimate
Fig. 1. Dietary interventions were shown to have an effect on the structural properties of bone. Dietary intervention with 20,000 IU/kg vitamin D3 is associated with greater failure
displacement, greater post-yield displacement and greater work-to-failure, when compared to the control. (A) Failure displacement, (B) post-yield displacement, (C) work-to-failure
and (D) ultimate force were determined by 3-point-bending. For all graphs (Control (1000 IU/kg) n = 10, 8000 IU/kg n = 10, 20,000 IU/kg n = 7), columns represent mean/group
and error bars indicate SEM, where *p b 0.05, **p b 0.01 and ***p b 0.001. N = newtons, mm=millimeters and J = joules.
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load compared to the control group (Table 1, Fig. 1D). Furthermore, di-
etary vitaminD3 levels did not lead to statistically signiﬁcant differences
in tibial length, tibial antero-posterior width or tibial medio-lateral
width (Table 1).Table 1
Structural properties.
Control
(1000 IU/kg)
8000 IU/kg 20,000 IU/kg
Tibial length (mm) 18.08 ± 0.2 17.58 ± 0.2 17.58 ± 0.1
Tibial anterior-posterior
width (mm)
1.209 ± 0.01 1.245 ± 0.02 1.238 ± 0.02
Tibial medial-lateral width (mm) 1.061 ± 0.03 1.068 ± 0.02 1.081 ± 0.04
Ultimate force (N) 9.99 ± 0.3 10.78 ± 0.2 10.02 ± 0.3
Ultimate displacement (mm) 0.561 ± 0.03 0.518 ± 0.02 0.491 ± 0.03
Stiffness (N/mm) 27.54 ± 0.9 29.73 ± 2.0 29.58 ± 1.8
Yield load (N) 9.48 ± 0.3 10.04 ± 0.3 9.28 ± 0.2
Yield displacement (mm) 0.421 ± 0.03 0.405 ± 0.03 0.354 ± 0.02
Failure force (N) 8.92 ± 0.4 9.26 ± 0.4 7.51 ± 0.5a
Failure displacement (mm) 0.76 ± 0.04 0.85 ± 0.05 1.03 ± 0.07bb
Tibiae from12week old femalemice that had been on a vitaminD3 dietary intervention for 4
weeks were subjected to three-point-bending and structural properties determined. Values
are presented as group mean ± SEM. n = 10 Control, 8000 IU/kg; n = 7 20,000 IU/kg.
a p b 0.05 vs 8000 IU.
bb p b 0.01 vs control.3.2. Effects of vitamin D3 dietary intervention on tibial material properties
The dietary level of 20,000 IU/kg vitamin D3was associatedwith sig-
niﬁcantly lower (80%) stress at the failure point, compared to the con-
trol (Fig. 2A). This high level of dietary vitamin D3 was also associated
with a signiﬁcantly greater strain at the failure point, compared to con-
trol (144%) (Fig. 2B) and a signiﬁcantly greater post-yield strain com-
pared to both the control (210%), and the 8000 IU/kg group (152%)
(Fig. 2C). The 20,000 IU/kg diet of vitamin D3 was associated with a sig-
niﬁcantly greater (145%) tibial toughness compared to the control (Fig.
2D). In contrast, none of these parameters were altered in mice given
the 8000 IU/kg vitamin D3 diet (Fig. 2A–D). No statistically signiﬁcant
differences between groups were observed in maximum stress, strain
at maximum stress or elastic modulus related to dietary levels of vita-
min D3 (Table 2). Nor was any statistically signiﬁcant change observed
in the stress or strain at the yield point of any samples, when subjected
to vitamin D3 dietary intervention (Table 2).
No dietary intervention was associated with any signiﬁcant changes
in the reference point indentation parameters (Table 3).3.3. Effects of vitamin D3 dietary intervention on bone morphology
μCT scans of the trabecular secondary spongiosa of the tibiae re-
vealed that a diet containing 20,000 IU/kg vitamin D3 resulted in a sig-
niﬁcantly greater trabecular bone volume fraction when compared to
the control (146%) and the 8000 IU/kg group (131%) (Fig. 3A). There
Fig. 2.Dietary interventionswith vitaminD3were shown to have aneffect on thematerial properties of bone. Dietary interventionwith 20,000 IU/kg vitaminD3 is associatedwith reduced
Failure Stress, greater failure strain, post-yield strain, and toughness when compared to the control. (A) Failure stress, (B) failure strain, (C) post-yield strain and (D) toughness were
determined by 3-point-bending. For all graphs (Control (1000 IU/kg) n = 10, 8000 IU/kg n = 10, 20,000 IU/kg n = 7), columns represent mean/group and error bars indicate SEM,
where *p b 0.05, **p b 0.01 and ***p b 0.001. MPa =megapascals.
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plementation (Fig. 3B). This high dosage of vitamin D3 was also associ-
ated with a signiﬁcantly lower trabecular separation (Fig. 3C) and
signiﬁcantly greater trabecular number (Fig. 3D) compared to the con-
trol. None of these parameters were changed in the 8000 IU/kg group.
The combination of all changes in all parameters contributing to the
overall greater trabecular bone volume fraction can be seen in the
models reconstructed from the μCT scans (Fig. 4).
Varying dietary vitamin D3 levels did not lead to statistically signiﬁ-
cant differences in cortical tissue mineral density, morphology, includ-
ing cortical area, marrow area, endocortical perimeter, corticalTable 2
Material properties.
Control
(1000 IU/kg)
8000 IU/kg 20,000 IU/kg
Elastic modulus (MPa) 6224.03 ± 191.0 6090.18 ± 511.5 5682.51 ± 160.4
Ultimate stress (MPa) 160.59 ± 5.6 159.02 ± 7.8 144.89 ± 6.6
Ultimate strain 0.038 ± 0.04 0.039 ± 0.002 0.037 ± 0.002
Yield stress (MPa) 152.51 ± 5.7 148.24 ± 8.2 134.35 ± 6.4
Yield strain 0.0306 ± 0.002 0.0303 ± 0.002 0.0263 ± 0.001
Failure stress (MPa) 143.72 ± 6.9 136.77 ± 8.9 108.48 ± 8.0b
Failure strain 0.0548 ± 0.003 0.0638 ± 0.004 0.0771 ± 0.006bb
Tibiae from 12 week old female mice that had been on a vitamin D3 dietary intervention
for 4 weeks were subjected to three-point-bending and the material properties were de-
termined. Values are presented as groupmean± SEM. n= 10 Control, 8000 IU/kg; n= 7
20,000 IU/kg.
b p b 0.05.
bb p b 0.01 vs control.thickness, polar moment of inertia or cross sectional moment of inertia
in either the x or y-direction (Table 4).4. Discussion
This study investigated the effects of dietary vitamin D3 on the me-
chanical properties and morphology of murine tibiae. We found that
provision of 20,000 IU/kg to 8week old femalemice for 4weeks was as-
sociated with greater bone strength, greater structural and material
ductility, and greater toughness. This level of dietary vitamin D3 was
also associated with signiﬁcantly higher trabecular bone volume frac-
tion but no detectable change in cortical structure.Table 3
Reference-point indentation test results.
Control
(1000 IU/kg)
8000 IU/kg 20,000 IU/kg
1st cycle indentation
distance (μm)
32.62 ± 1.4 31.19 ± 1.8 32.34 ± 1.9
Total indentation distance (μm) 35.61 ± 1.4 34.38 ± 2.1 34.25 ± 1.8
Indentation distance
increase (μm)
5.65 ± 0.6 5.43 ± 0.5 4.41 ± 0.2
Avg unloading (N/μm) 0.204 ± 0.006 0.205 ± 0.011 0.235 ± 0.011
Avg loading slope (N/μm) 0.168 ± 0.007 0.163 ± 0.008 0.183 ± 0.009
Avg energy dissipated (μJ) 4.88 ± 0.3 5.09 ± 0.4 4.27 ± 0.3
Tibiae from 12 week old female mice that had been on a vitamin D3 dietary intervention
for 4weekswere subjected to reference point indentation and the results recorded. Values
are presented as group mean ± SEM. n = 10 Control, 8000 IU/kg; n = 7 20,000 IU/kg.
Fig. 3.Dietary interventionswith vitaminD3were shown to have an effect on themorphology of trabecular bone. Dietary interventionwith 20,000 IU/kg vitaminD3 is associatedwith greater
trabecular bone volume fraction, separation and number when compared to the control. (A) Trabecular Bone Volume fraction, (B) Thickness, (C) Trabecular Separation and (D) Trabecular
Numberwere determined by μCT analysis. For all graphs (Control (1000 IU/kg) n=10, 8000 IU/kg n=10, 20,000 IU/kg n=7), columns representmean/group and error bars indicate SEM,
where *p b 0.05 and **p b 0.01. mm=millimeters.
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level of vitamin D3 is consistent with previous studies (Lee et al.,
2010), where vitamin D interventions resulted in greater effects on tra-
becular but not cortical bone. Lee et al. (2010) demonstrated by μCT that
increasing dietary vitamin D3 levels administered to 10 week old rats
(from approximately 100 IU/kg to 600 IU/kg), led to greater femoral
and vertebral trabecular bonemasswith thehigher doses. Again, consis-
tent with our observations, they did not observe any change in cortical
bone dimensions; indicating that vitamin D dietary interventionsFig. 4. Reconstructed images, using ParaView (version 3.14.1), of the sample from each group;
volume fraction closest to that of the group mean.predominantly modify trabecular rather than cortical bone structure.
They observed a signiﬁcant effect at a lower Vitamin D3 dosage com-
pared to our study, likely due to the use of a vitamin D3 deﬁcient rat
model and a signiﬁcantly longer intervention period (20 weeks com-
pared to 4 weeks).
Although we observed no signiﬁcant change in cortical dimensions,
the mechanical properties of cortical bone were greatly altered by the
highest level of vitamin D3 supplementation, indicating a likely change
in bone composition. The greater post-yield displacement, post-yield(A) Control (1000 IU/kg), (B) 8000 IU/kg and (C) 20,000 IU/kg, with the trabecular bone
Table 4
Bone morphology.
Control (1000 IU/kg) 8000 IU/kg 20,000 IU/kg
Marrow area (mm2) 0.140 ± 0.006 0.145 ± 0.007 0.142 ± 0.005
Cortical area (mm2) 0.214 ± 0.005 0.232 ± 0.007 0.232 ± 0.009
Endocortical perimeter (mm) 0.637 ± 0.009 0.652 ± 0.007 0.664 ± 0.013
Periosteal perimeter (mm) 2.811 ± 0.03 2.934 ± 0.04 2.946 ± 0.06
Tissue mineral density (g·cm3) 0.96 ± 0.007 0.94 ± 0.009 0.95 ± 0.009
Cortical thickness (mm) 0.218 ± 0.004 0.229 ± 0.006 0.230 ± 0.006
Mean polar moment of inertia (mm4) 0.1267 ± 0.004 0.1395 ± 0.01 0.1406 ± 0.01
Cross sectional moment of inertia x (mm4) 0.0675 ± 0.003 0.0784 ± 0.003 0.0786 ± 0.006
Cross sectional moment of inertia y (mm4) 0.0566 ± 0.007 0.0611 ± 0.006 0.0620 ± 0.004
Tibiae from 12 week old female mice that had been on a vitamin D3 dietary intervention for 4 weeks had their length measured with calipers and then were imaged with a μCT scanner
from which their bone morphology was determined. Values are presented as group mean ± SEM. n = 10 Control, 8000 IU/kg; n = 7 20,000 IU/kg.
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kg dietary intervention indicated that both the structural and material
ductility were greater than in mice supplied with the control diet. Fur-
thermore, dietary levels of 20,000 IU/kg vitamin D3 resulted in the
need for a higher energy requirement for bone fracture, both over the
whole bone structure (work-to-failure) and the material (toughness).
Previous studies reported that treatment of ovariectomised rats with
0.5 μg/kg/day 1,25-dihydroxyvitamin D3 (1,25OHD3) signiﬁcantly in-
creased toughness compared to both the ovariectomized control and
non-ovariectomized control (Aerssens et al., 1994; Zimmermann et al.,
2015). While our study did not measure 1,25OHD3 levels, previous re-
ports (Aerssens et al., 1994; Zimmermann et al., 2015) suggest that it
is likely that the greater toughness observed with the 20,000 IU/kg die-
tary intervention is due to an increased level of circulating 1,25OHD3,
resulting in amore ductile and tougher bone; however thiswill need fu-
ture conﬁrmation.
Thematerial properties of bone, speciﬁcally the easewithwhich col-
lagen ﬁbrils slide over each other can increase toughness since in-
creased ability to slide will allow the bone to deform and absorb any
applied loads (Zimmermann et al., 2015). Through reference point
micro-indentation (RPI) we examined the material properties of the
bone but observed no differences between any of our dietary interven-
tion groups. Paschalis et al., (2016) (Paschalis et al., 2016) reported that
vitamin D and calcium supplementation for a three year period in post-
menopausal osteoporosis signiﬁcantly altered bonemineral and organic
matrix quality. The lack of an obvious change using RPI may be due to
insufﬁcient precision of this method; this could be overcome through
the use of a nano- or pico-indentor. Additionally, a limitation of RPI is
that it only examines the material properties on the periosteal surface.
It is possible that our observed changes in material properties may be
due to the incorporation of mineral at a deeper level or on the
endocortical surface. Future studies using Raman microspectroscopy
(as used by Paschalis et al.)may permit these questions to be addressed.
The greater ductility and toughness observed in the bones of our
growing mice suggest that dietary supplementation with vitamin D3
may be a suitable method to increase peak bone mass during adoles-
cence to prevent development of osteoporosis later in life. This strategy
of decreasing fracture risk in the elderly by optimising bone health dur-
ing bonedevelopmentwas previously suggested by Rizzoli et al. (2010),
and was supported by a positive correlation between childhood bone
health and bone health in adulthood. Further evidence to support this
strategy comes from a number of intervention studies in adolescents
which have reported signiﬁcant increases in bone mineral content
(BMC) and bonemineral density (BMD) with vitamin D3 supplementa-
tion. Viljakainen et al. (2006) reported that daily tablets of 5 and 10 μg
vitamin D3 supplementation (approximately 200–400 IU/d) for 1 year
in adolescent girls resulted in signiﬁcant increases in femoral bone
BMC. Likewise El-Hajj Fuleihan et al. (2006) treated adolescent girls
with 14,000 IU (equivalent to 2000 IU/d) for 1 year and observed an in-
crease in hip BMC. Finally, Du et al. (2004) observed in 10–12 year old
girls that daily consumption of milk fortiﬁed with 8 μg vitamin D3(320 IU/d) for a period of 2 years resulted in size adjusted increases in
BMC and BMD. Our experiments were conducted on 8-week-old female
mice, which are post-puberty, but still growing, and in these mice we
saw an increase in bone strength through a 20,000 IU/kg dietary supple-
mentation, suggesting that clinical dietary vitamin D3 supplementation
may be an avenue to increase bone health in young, growing bones, and
could result in decreased fracture risk in adulthood. However, this re-
quires additional research.
In conclusion, we observed that high levels of dietary vitamin D3 in
adult mice resulted in greater tibial ductility, toughness and greater tra-
becular bone volume fraction. Our results suggest that high levels of di-
etary vitamin D3 may be suitable for achieving a higher peak bonemass
in adulthood and thereby preventing osteoporosis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bonr.2017.02.001.References
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